Medical research

An asthma vaccine effective in mice

Inserm teams led by Laurent Reber (Infinity, Toulouse) and Pierre Bruhns (Humoral Immunity, Institut Pasteur, Paris) and French company NEOVACS have developed a vaccine that could induce long-term protection against allergic ...

Medical research

Shelf-stable vaccines avoid waste, expand access

More than 50% of all vaccines are wasted due to errors in transportation or storage, according to the World Health Organization. A research team led by Northwestern and Cornell universities has developed a new manufacturing ...

HIV & AIDS

Recommendations updated for meningococcal vaccine in HIV

(HealthDay)—In the Nov. 4 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report, new recommendations are presented for meningococcal conjugate vaccination among HIV-infected ...

Diseases, Conditions, Syndromes

Which vaccinations should I get as an adult?

Before vaccines were developed, infectious diseases such as diphtheria, tetanus and meningitis were the leading cause of death and illness in the world. Vaccines are one of the greatest public health achievements in history, ...

Health

ACIP announces recommended 2013 adult immunization schedule

The Center for Disease Control and Prevention's Advisory Committee on Immunization Practices (ACIP) announced its recommended 2013 adult immunization schedule that includes important updates to the pneumococcal, Tdap (tetanus, ...

Diseases, Conditions, Syndromes

Bell's palsy tied to quadrivalent meningococcal vaccine

(HealthDay)—Bell's palsy is the only prespecified adverse event associated with the MenACWY-CRM quadrivalent meningococcal conjugate vaccine, according to a study published online Dec. 26 in Pediatrics.

Diseases, Conditions, Syndromes

Vaccine is a cost-effective solution for countries burdened by typhoid

Introducing a typhoid conjugate vaccine (TCV) into routine child vaccine schedules and conducting a catch-up campaign to vaccinate all children up to age 15 is a cost-effective solution for many low- to middle-income countries ...

page 1 from 6